Stocks to Watch: Regions, Google, RIM
NEW YORK -- Federal agencies are examining allegations that Regions Financial (RF) improperly classified loans that went bad during the financial crisis, The Wall Street Journal reported, citing depositions filed as part of a civil lawsuit against the bank.
The depositions were unsealed by a federal judge in Birmingham, Ala., Regions' headquarters, earlier in December. The depositions emerged as part of a lawsuit brought in 2010 by two pension funds that own Regions stock. The funds allege that Regions hid problems by moving loans out of nonaccrual status, which means interest payments were overdue and collection of the principal unlikely, according to the Journal.
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
Google's (GOOG) newly acquired Motorola Mobility unit is working on a handset -- known internally as the "X phone" -- in an effort to provide more competition for Apple, the Journal said, citing people familiar with the matter. Motorola is designing the handset with cutting-edge features to stand apart from existing phones when it is released in 2013, the people said. But Google's new hardware unit has run into certain hurdles that have caused the company to rethink some initial plans for the X phone like using a bendable screen, the people told the newspaper. 2013: Google Leads a Phone Price War
Research In Motion (RIMM) shares fell 23% to $10.91 on Friday after the BlackBerry maker said in an earnings conference call it would change the way it charges customers service fees, putting a key source of revenue at risk.
Herbalife (HLF) shares fell 19% on Friday to $27.27 after William Ackman, the head of Pershing Square Capital Management, unveiled a 334-page presentation on why he feels the supplements maker is a pyramid scheme worth $0. Ackman has caused a drop of more than 35% in Herbalife's share price after disclosing last week that he is short the company's shares and feels its multi-level marketing arrangement is more of a fraudulent pyramid scheme than a multi-billion dollar retail business. Herbalife Defenders Get Personal With Ackman, Shorts
Alexza Pharmaceuticals (ALXA) received approval Friday from the Food and Drug Administration for Adasuve, a treatment for schizophrenia and bipolar disorder that can be inhaled.
-- Written by Joseph Woelfel
>To contact the writer of this article, click here: Joseph Woelfel >To submit a news tip, send an email to: tips@thestreet.com.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV